(Alliance News) - Aptamer Group PLC said on Tuesday that it has extended its contract with Unilever PLC for the development of novel Optimer binders for use in deodorant products.
The York, England-based biotechnology firm will partner with Unilever, the London-based consumer goods firm, to continue its work in testing Optimer binders as active ingredients in deodorants.
Aptamer said the use of active ingredients like Optimer binders in deodorant products is "highly novel" and "holds the potential for enhanced efficacy for customer products". Optimer binders target the C-S Lyase bacterial enzyme, which is critical in the generation of auxiliary odour.
The contract follows successful laboratory tests of the Optimer binders, allowing the partnership to progress to planned in-vivo studies before the end of 2024.
Aptamer Chief Executive Officer Arron Tolley said: "The continued advancement of our Optimer binders in collaboration with Unilever is a significant milestone for Aptamer Group. With efficacy testing on the horizon, we are optimistic about bringing these binders to market in the coming years and look forward to discussing commercial opportunities with Unilever upon successful trial outcomes."
Aptamer Group share prices were up 8.7% to 0.25 pence each in London on Tuesday morning.
By Emily Parsons, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.


LONDON, July 1 (Reuters) - A rush of foreign bids for UK companies has put Britain on track to outstrip all previous records for dealmaking in 2026,...


* Thorne attracted strategic interest, including a bid from Haleon, sources say


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


NEW YORK, April 3 (Reuters) - The private equity owner of Dr. Squatch is exploring a sale of the men's grooming brand that it hopes will value the c...


(Alliance News) - Blue-chip stock prices in Europe closed higher on Tuesday, showing little signs of nerves ahead of Wednesday's Federal Reserve decis...


(Sharecast News) - London markets closed with a mixed performance on Tuesday, as investors weighed the implications of Japan's decision to end negativ...


(Alliance News) - Stock prices in London were down at midday on Tuesday, as investors sat on their hands ahead of interest rate decisions from the UK ...


(Alliance News) - Stock prices in London lacked direction at the open on Tuesday, as investors digested interest rate decisions from Japan and Austral...


(Alliance News) - Unilever PLC on Tuesday said it plans to spin off its ice cream business and cut 7,500 jobs as it picks up the pace of its reorganis...


(Alliance News) - Stocks in London are called to open slightly lower, following some mixed trade across Asian markets.